At 8.9% CAGR, the North America DNA Extraction, Isolation, and Purification Market is Projected to be Worth US$ 3,429.95 Million by 2030, Says Business Market Insights

According to Business Market Insights' research, the North America DNA extraction, isolation, and purification market was valued at US$ 1,734.31 million in 2022 and is expected to reach US$ 3,429.95 million by 2030, registering a CAGR of 8.9% from 2022 to 2030. Technological advancements associated with instruments and emerging applications of extracted and purified DNA are among the critical factors attributed to the North America DNA extraction, isolation, and purification market expansion.

The rapidly progressing automation technology has resulted in the development of automated nucleic acid extraction systems. An automated nucleic acid extraction process can benefit through its ability to decrease labor costs, increase worker safety, and improve result reproducibility and quality. Moreover, the ongoing efforts toward the development of a portable, miniature extraction system or an all-in-one biomolecule extraction system would introduce new trends in the DNA extraction, isolation, and purification market in the coming years. For instance, Promega Corporation a one of the leading players offers Maxwell, a complete robotic nucleic acid purification system. Moreover, robotic automation in laboratories would support the trend of miniaturization. Smaller systems with lower throughput are more suitable for clinical laboratory workload. Additionally, robotic automation systems are relatively inexpensive to implement, improving turnaround times and lowering labor costs.

On the contrary, high cost of process and need for highly skilled workforces hampers the growth North America DNA extraction, isolation, and purification market.

Based on type, the North America DNA extraction, isolation, and purification market is categorized into kits, instrument, and reagent. The kits segment held 63.5% share of the North America DNA extraction, isolation, and purification market in 2022, amassing US$ 1,101.71 million. It is projected to garner US$ 2,230.19 million by 2030 to expand at 9.2% CAGR during 2022-2030.

In terms of method, the North America DNA extraction, isolation, and purification market is bifurcated into chemical method and physical method. The chemical method segment held 83.0% share of the North America DNA extraction, isolation, and purification market in 2022, amassing US$ 1,438.82 million. It is projected to garner US$ 2,852.52 million by 2030 to expand at 8.9% CAGR during 2022-2030. The chemical method is further subsegmented into phenol chloroform, silica gel, proteinase, and others. The physical method is further subsegmented into magnetic bead and paper.

By sample type, the North America DNA extraction, isolation, and purification market is segmented into blood, body fluid, and others. The blood segment held 54.1% share of North America DNA extraction, isolation, and purification market in 2022, amassing US$ 938.55 million. It is projected to garner US$ 1,871.50 million by 2030 to expand at 9.0% CAGR during 2022-2030.

By source, the North America DNA extraction, isolation, and purification market is segmented into genomic and microbial. The genomic segment held 78.4% share of North America DNA extraction, isolation, and purification market in 2022, amassing US$ 1,358.84 million. It is projected to garner US$ 2,705.99 million by 2030 to expand at 9.0% CAGR during 2022-2030.The microbial segment is further subsegmented into bacteria and virus.

Based on application, the North America DNA extraction, isolation, and purification market is categorized into PCR test, next generation sequencing, micro array, and others. The next generation sequencing segment held 38.6% share of the North America DNA extraction, isolation, and purification market in 2022, amassing US$ 669.53 million. It is projected to garner US$ 1,339.89 million by 2030 to expand at 9.1% CAGR during 2022-2030. The PCR test segment is further subsegmented into qPCR, multiplex PCR, 16S PCR, and others.

By end-user, the North America DNA extraction, isolation, and purification market is segmented into diagnostic center and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The diagnostic center and research laboratories segment held 49.9% share of North America DNA extraction, isolation, and purification market in 2022, amassing US$ 866.17 million. It is projected to garner US$ 1,715.08 million by 2030 to expand at 8.9% CAGR during 2022-2030.

Based on country, the North America DNA extraction, isolation, and purification market is categorized into the US, Canada, and Mexico. The US held 82.2% share of North America DNA extraction, isolation, and purification market in 2022, amassing US$ 1,425.59 million. It is projected to garner US$ 2,832.12 million by 2030 to expand at 9.0% CAGR during 2022-2030.

Key players operating in the North America DNA extraction, isolation, and purification market are Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc, Illumina Inc, Merck KGaA, Qiagen NV, Takara Bio Inc, and Thermo Fisher Scientific Inc, among others.

- In Aug 2023, Thermo Fisher Scientific launched a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency, and profitability with an industry-leading two-day turnaround time. Providing insights on chromosomal variants for a wide range of prenatal, postnatal and oncology research applications, the Applied Biosystems CytoScan HD Accel array analyzes the whole human genome and provides improved coverage in more than 5,000 critical genome regions.

- In Jul 2023, QIAGEN launched of the QIAseq Normalizer Kits that give researchers a fast, convenient, and cost-effective method to pool different DNA libraries for best-quality results from next-generation sequencing (NGS) runs.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com